Revolutionizing Heart Attack Treatment: The Fusion of Nanomedicine and Optofluidic Catheters
This innovative medical technology for acute myocardial infarction (AMI) leverages two inventions: a light-activated nitric oxide (NO) nanomedicine and an optofluidic catheter. The catheter delivers light and nanomedicine, enabling localized and rapid NO generation near the infarction zone. We demonstrated treatment efficacy on a pig AMI model, showing significantly reduced myocardial necrosis and apoptosis, and improved ventricular function.
A deep learning-powered novel artificial intelligence algorithm and syste m to assist in the identification of pneumoperitoneum on abdominal com puted tomography
Ultrahigh-Sensitive Detection Platform Powered by Semiconductor-based Biosensor for the evaluation of Treatment on Acute Myeloid Leukemia
One Model Fit All: Revolutionary One-Stop Shop System for Predicting Co ronary Stenosis without Normal Database in Myocardial Perfusion Imagin g
Development of novel cannabinoid CB1receptor antagonists with high oral absorption and no central adverse effects for the treatment of cardiovascular diseases
Technology maturity：Trial production
Exhibiting purpose：Display of scientific results
Trading preferences：Negotiate by self
Coming soon!